Mind Medicine (Mind Medicine) Interest Expense : $-0.43 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Mind Medicine Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Mind Medicine's interest expense for the three months ended in Mar. 2024 was $ -0.43 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.43 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Mind Medicine's Operating Income for the three months ended in Mar. 2024 was $ -22.20 Mil. Mind Medicine's Interest Expense for the three months ended in Mar. 2024 was $ -0.43 Mil. Mind Medicine did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Mind Medicine Interest Expense Historical Data

The historical data trend for Mind Medicine's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mind Medicine Interest Expense Chart

Mind Medicine Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Interest Expense

-0.16

-0.36

Mind Medicine Quarterly Data
	Sep19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial													-0.08	-	-	-	-0.43

Mind Medicine Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.43 Mil.

Mind Medicine (OTCPK:MMCWF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Mind Medicine's Interest Expense for the three months ended in Mar. 2024 was $-0.43 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-22.20 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $14.19 Mil.

Mind Medicine's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Mind Medicine did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Mind Medicine (Mind Medicine) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mind Medicine Inc (OTCPK:MMCWF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

MNMD:USA MMQ:Germany MMED:Canada

Address

One World Trade Center, Suite 8500, New York, NY, USA, 10007

Website

https://www.mindmed.co

Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.